This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Pathology

Authoring team

PNH is an acquired membrane disorder usually caused by a mutation in an X - linked gene. PNH cell membranes lack two important glycoproteins - decay accelerating factor (DAF) and homologous restriction factor (HRF) - which normally impede complement activation.

As a result, PNH cells are more sensitive to activated complement since their ability to fix C3b is increased, and the terminal lytic sequence of complement is more able to penetrate the cell membrane. Variations in the degree of complement sensitivity result in part, from differences in the proportion of stem cells affected.

PNH cells also show increased susceptibility to lysis by hydrogen peroxide and reduced acetylcholinesterase activity.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.